IBM traded as high as $162 pre-earnings on Tuesday, then below its 200-day simple moving average of $152.13. The weekly chart for IBM was poised to be positive with the stock above its technical ‘reversion to the mean’ at $158.05. …
IBM's efforts to concentrate on high-growth businesses like the cloud have helped Big Blue make progress, but there's a lot further to go before investors can …
On April 17, IBM announced shrinking margins and flat currency-adjusted revenue—and it failed to boost its forecast for the year. The stock had lost 7.6% …
The Dow industrials ended lower Wednesday as IBM’s shares got walloped; however, gains in shares of energy-related firms helped the broader market post modest gains. Wall Street showed a muted reaction to the release of the Beige …
IBM shares fell more than 5% on Tuesday after the company announced its first …
IBM said that its fiscal year profit would be $13.80 per share, just shy of Wall Street’s expectations of $13.83. The minor disappointment translated into a huge …
Decent Zacks Rank The stock has a Zacks Rank #3 (Hold) and a VGM (Value, Growth, Momentum) Score of A. Its Zacks Industry Rank is in the top 11%. ETFs to Watch If you have patience and can wait till IBM's digitalization and a host of …
The Dow Jones Industrial Average slipped as IBM shares tanked on disappointing …
IBM 's shares have underperformed the broader market on a year ... The approval of Gilead's latest triple HIV therapy, Biktarvy, is likely to provide an impetus to the stock as Gilead is now banking on its HIV franchise and newer avenues …
U.S. stock-index futures pointed to a slightly lower open on Thursday ... On Wednesday, the Dow DJIA, -0.16% closed slightly lower, hurt by a selloff for IBM IBM, -7.53% after the tech giant’s latest results, while the S&P 500 SPX, …